Intelligent Bio Solutions Inc. (INBS) Non-Current Deffered Revenue (2021 - 2022)

Intelligent Bio Solutions' Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $1.6 million for Q4 2022.

• In Q4 2022, Non-Current Deffered Revenue rose 35.39% year-over-year to $1.6 million; the TTM figure through Dec 2022 stood at $1.6 million (up 35.39% YoY), while the FY2022 annual figure was $1.1 million, down 65.29% from the prior year.
• Non-Current Deffered Revenue for Q4 2022 stood at $1.6 million, down from $2.6 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $3.1 million in Q2 2021, with the low at $1.1 million in Q2 2022.